Abstract:Monitoring and quantifying host cell proteins (HCPs) in biotherapeutics production processes is crucial to ensure product quality, stability, and safety. Liquid chromatography-mass spectrometry (LC-MS) analysis has emerged as an important tool for identifying and quantifying individual HCPs. However, LC-MS-based approaches face challenges due to the wide dynamic range between HCPs and the therapeutic protein, as well as laborious sample preparation and long instrument time. To address these limitations, we evaluated the application of parallel accumulation-serial fragmentation combined with data-independent acquisition (diaPASEF), to HCP analysis for biopharmaceutical process development applications. We evaluated different library generation strategies and LC methods, demonstrating the suitability of these workflows for various HCP analysis needs such as in-depth characterization and high-throughput analysis of process intermediates. Remarkably, the diaPASEF approach enabled the quantification of hundreds of HCPs that were undetectable by a standard data-dependent acquisition mode while considerably improving sample requirement, throughput, coverage, quantitative precision, and data completeness.

What problem does this paper attempt to address?

This paper attempts to solve the problems of host cell protein (HCPs) monitoring and quantification in the biopharmaceutical production process. Specifically, the article focuses on how to improve the detection sensitivity, coverage, quantification accuracy, and data integrity of HCPs, especially in high - throughput analysis. ### Main problems 1. **Wide dynamic range**: In drug substances, the concentration difference between HCPs and therapeutic proteins is very large (> 10^6), which makes it difficult for traditional LC - MS methods to effectively detect rare HCPs. 2. **Complex sample preparation**: Traditional LC - MS methods require a complex sample preparation process, and the instrument running time is long (> 2 hours/sample), which limits the sample throughput. 3. **Limitations of data - dependent acquisition (DDA)**: The DDA method can only select the most abundant precursor ions for fragmentation and MS2 spectrum acquisition, resulting in information loss, especially for rare precursor ions, and some data have poor reproducibility. ### Solutions To overcome the above challenges, the author introduced the parallel accumulation - serial fragmentation combined with data - independent acquisition (diaPASEF) technology and evaluated its application in HCP analysis. diaPASEF achieves higher selectivity and sensitivity through synchronous ion mobility separation and mass selection, enabling more comprehensive detection and quantification of HCPs. ### Main contributions 1. **Improved detection sensitivity and coverage**: The diaPASEF method can quantify hundreds of HCPs that cannot be detected by traditional DDA methods. 2. **Increased sample throughput**: The optimized workflow significantly reduces sample requirements and analysis time while maintaining high throughput. 3. **Improved quantification accuracy and data integrity**: The diaPASEF method performs well in terms of quantification accuracy and data integrity, especially when dealing with complex samples. ### Experimental verification The author verified the effectiveness of the diaPASEF method through a series of experiments, including: - Optimizing the ion - mobility - coupled gas - phase fractionation (IM - GPF) scheme. - Evaluating different spectral library generation strategies and LC methods. - High - throughput analysis of mAb2 HCCFs samples, demonstrating its potential in practical applications. In conclusion, this study provides a new solution for the efficient monitoring and quantification of HCPs in the biopharmaceutical production process, which helps to ensure product quality, stability, and safety.

diaPASEF Enables High-throughput Proteomic Analysis of Host Cell Proteins for Biopharmaceutical Process Development

A Data-Independent Acquisition (Dia)-Based Quantification Workflow for Proteome Analysis of 5000 Cells.

Detection and quantitation of host cell proteins in monoclonal antibody drug products using automated sample preparation and data-independent acquisition LC-MS/MS

P28-S Digging Deeper and Faster into Proteome by IgY-Immunoaffinity Fractionation

Toward Unbiased Identification and Comparative Quantification of Host Cell Protein Impurities by Automated Iterative LC-MS/MS (HCP-AIMS) for Therapeutic Protein Development

Technical advancement and practical considerations of LC-MS/MS-based methods for host cell protein identification and quantitation to support process development

Evaluation of Protein Identification and Quantification by the Diapasef Method on Timstof SCP

Multidimensional Separation Using HILIC and SCX Pre-fractionation for RP LC-MS/MS Platform with Automated Exclusion List-based MS Data Acquisition with Increased Protein Quantification

High-throughput proteome profiling with low variation in a multi-center study using dia-PASEF

Toward Biomarker Development in Large Clinical Cohorts: an Integrated High-Throughput 96-Well-plate-based Sample Preparation Workflow for Versatile Downstream Proteomic Analyses.

Comprehensive host cell proteins profiling in biopharmaceuticals by a sensitivity enhanced mass spectrometry strategy using TMT-labeling and signal boosting

A fully automated system with online sample loading, isotope dimethyl labeling and multidimensional separation for high-throughput quantitative proteome analysis.

Optimized Sample Preparation and Data Processing of Data-Independent Acquisition Methods for the Robust Quantification of Trace-Level Host Cell Protein Impurities in Antibody Drug Products

Identification and Quantification of a Problematic Host Cell Protein to Support Therapeutic Protein Development.

Filling the gaps in peptide maps with a platform assay for top-down characterization of purified protein samples

Fully Integrated And Multiplexed Sample Preparation Technology For Sensitive Interactome Profiling

An Automated High-throughput Affinity Capture-Mass Spectrometry Platform with Data-Independent Acquisition

Optimization of Data-Independent Acquisition Mass Spectrometry for Deep and Highly Sensitive Proteomic Analysis

Quantitative Chemoproteomic Profiling with Data-Independent Acquisition-Based Mass Spectrometry

Ultra-deep proteomics by Thin-diaPASEF with a 60-cm long column system

Using variable data independent acquisition for capillary electrophoresis-based untargeted metabolomics